LIQUIDIA CORPORATION - COMMON STOCK

Liquidia Corporation Reports First Quarter 2025 Financial Results and Provides Corporate Update

08 май 2025 06:30:00 Источник Nasdaq GlobeNewswire

Liquidia Corporation to Present at BofA Securities 2025 Health Care Conference

06 май 2025 08:00:00 Источник Nasdaq GlobeNewswire

District Court Dismisses Dispute Filed by United Therapeutics Against Liquidia

02 май 2025 17:28:34 Источник Nasdaq GlobeNewswire

Liquidia Corporation to Report First Quarter 2025 Financial Results on May 8, 2025

01 май 2025 08:00:00 Источник Nasdaq GlobeNewswire

UPDATE – Liquidia Corporation to Present at the 24th Annual Needham Virtual Healthcare Conference

01 апр 2025 10:33:25 Источник Nasdaq GlobeNewswire

Liquidia Corporation to Present at the 24th Annual Needham Virtual Healthcare Conference

01 апр 2025 08:00:00 Источник Nasdaq GlobeNewswire

Liquidia Corporation Announces FDA Acceptance of New Drug Application Resubmission for YUTREPIA™ (treprostinil) Inhalation Powder

28 мар 2025 09:30:49 Источник Nasdaq GlobeNewswire

Liquidia Announces Poster Presentations at the American Thoracic Society (ATS) 2025 International Conference

27 мар 2025 08:00:00 Источник Nasdaq GlobeNewswire

Liquidia Corporation Reports Full Year 2024 Financial Results and Provides Corporate Update

19 мар 2025 06:30:00 Источник Nasdaq GlobeNewswire

Liquidia Corporation Strengthens Financial Position by Amending HealthCare Royalty Agreement to Incrementally Add Up to $100 Million

18 мар 2025 08:00:00 Источник Nasdaq GlobeNewswire

Liquidia Corporation to Report Full Year 2024 Financial Results on March 19, 2025

12 мар 2025 08:00:00 Источник Nasdaq GlobeNewswire

Liquidia Corporation to Present at 43rd Annual J.P. Morgan Healthcare Conference

08 янв 2025 08:00:00 Источник Nasdaq GlobeNewswire

Liquidia Corporation Reports Third Quarter 2024 Financial Results and Provides Corporate Update

13 ноя 2024 06:30:00 Источник Nasdaq GlobeNewswire

Liquidia to Present at the Stifel 2024 Healthcare Conference

12 ноя 2024 08:00:00 Источник Nasdaq GlobeNewswire

Liquidia Corporation to Report Third Quarter 2024 Financial Results on November 13, 2024

06 ноя 2024 08:00:00 Источник Nasdaq GlobeNewswire

Liquidia Corporation to Report Third Quarter 2024 Financial Results on November 11, 2024

04 ноя 2024 08:00:00 Источник Nasdaq GlobeNewswire

United States Supreme Court Declines to Review Rulings that Invalidate United Therapeutics’ Patent

07 окт 2024 10:00:07 Источник Nasdaq GlobeNewswire

Liquidia and Pharmosa Biopharm Expand Collaboration to Develop Sustained Release Inhaled Treprostinil (L606)

02 окт 2024 06:00:00 Источник Nasdaq GlobeNewswire

Liquidia Announces Poster Presentation and Medical Theater at the CHEST 2024 Annual Meeting

30 сен 2024 08:00:00 Источник Nasdaq GlobeNewswire

Court Finds United Therapeutics’ Interference with Launch of Generic Treprostinil Injection Caused Losses of More Than $137 Million

16 сен 2024 09:41:30 Источник Nasdaq GlobeNewswire